DE68900892D1 - Zusammenstellung zur behandlung der osteoporose beim menschen. - Google Patents

Zusammenstellung zur behandlung der osteoporose beim menschen.

Info

Publication number
DE68900892D1
DE68900892D1 DE8989104086T DE68900892T DE68900892D1 DE 68900892 D1 DE68900892 D1 DE 68900892D1 DE 8989104086 T DE8989104086 T DE 8989104086T DE 68900892 T DE68900892 T DE 68900892T DE 68900892 D1 DE68900892 D1 DE 68900892D1
Authority
DE
Germany
Prior art keywords
people
composition
treating osteoporosis
osteoporosis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989104086T
Other languages
English (en)
Inventor
Samuel Edelstein
David Ladkani
Shaul Kadosh
Beni Shalita
Ze Ev Mazor
Ben Zion Weiner
Jacob Menczel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Yeda Research and Development Co Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22628816&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68900892(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd, Yeda Research and Development Co Ltd filed Critical Teva Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of DE68900892D1 publication Critical patent/DE68900892D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8989104086T 1988-03-23 1989-03-08 Zusammenstellung zur behandlung der osteoporose beim menschen. Expired - Lifetime DE68900892D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17269988A 1988-03-23 1988-03-23

Publications (1)

Publication Number Publication Date
DE68900892D1 true DE68900892D1 (de) 1992-04-09

Family

ID=22628816

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989104086T Expired - Lifetime DE68900892D1 (de) 1988-03-23 1989-03-08 Zusammenstellung zur behandlung der osteoporose beim menschen.

Country Status (9)

Country Link
EP (1) EP0335140B1 (de)
JP (1) JPH02231425A (de)
AU (1) AU611266B2 (de)
CA (1) CA1340743C (de)
DE (1) DE68900892D1 (de)
ES (1) ES2042831T3 (de)
GR (1) GR3004841T3 (de)
IL (1) IL89392A (de)
ZA (1) ZA891894B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69426997T2 (de) * 1993-02-23 2001-11-15 Heikki Sirkkola Die Verwendung eines Calciumpräparates in einem Medikament zur Behandlung von an Hypocalcämie leidenden Milchkühen
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
DE19503190A1 (de) * 1995-02-01 1996-08-08 Dietl Hans Mittel zur Beeinflussung von Störungen der Knochenbildung
GB2304285A (en) * 1995-08-22 1997-03-19 Sunnimex Ltd Pharmaceutical and/or dietetic formulation
WO2009087652A2 (en) * 2007-10-19 2009-07-16 Usv Limited Pharmaceutical compositions of calcitriol and mineral supplements
DE202010012099U1 (de) 2010-09-02 2010-11-11 Hexal Ag Vitaminzusammensetzung und Darreichungsform umfassend Vitamin D3 geeignet für die Osteoporoseprophylaxe und/oder Behandlung
CN104273541A (zh) * 2014-10-29 2015-01-14 成都健怡营销策划有限公司 一种增加骨密度的保健品

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6089422A (ja) * 1983-10-24 1985-05-20 Kureha Chem Ind Co Ltd 抗骨粗鬆症剤
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof

Also Published As

Publication number Publication date
EP0335140A1 (de) 1989-10-04
GR3004841T3 (de) 1993-04-28
IL89392A0 (en) 1989-09-10
AU3108289A (en) 1989-09-28
IL89392A (en) 1993-02-21
EP0335140B1 (de) 1992-03-04
ES2042831T3 (es) 1993-12-16
JPH02231425A (ja) 1990-09-13
AU611266B2 (en) 1991-06-06
CA1340743C (en) 1999-09-14
ZA891894B (en) 1989-11-29

Similar Documents

Publication Publication Date Title
ATE112963T1 (de) Gewebeentzusammensetzung und verfahren.
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
DE68918142D1 (de) Zusammensetzungen und Verfahren zur kontrollierten Freisetzung von Duftstoffen.
DE68912237D1 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
ATE110556T1 (de) Verbesserungen bei der behandlung von zähnen.
DE68907909D1 (de) Praeparat zur behandlung von erektionsstoerungen.
DE3579151D1 (de) Vorrichtung zur behandlung der oberschenkelknochenbrueche.
EP0604433A4 (de) Zusammensetzung und methode zur behandlung von krankheiten.
DE3483040D1 (de) Maschinelesbares dokument und dessen behandlung.
ATE84224T1 (de) Desinfektionsverfahren sowie zusammensetzung dafuer.
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
DE69033413D1 (de) Mittel zur Behandlung von Metalloberflächen
DE68900892D1 (de) Zusammenstellung zur behandlung der osteoporose beim menschen.
DE68906853D1 (de) Flussmittelzusammensetzung und verfahren zur herabsetzung des zinngehalts in blei-zinn-lotverbindungen.
NO893892L (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
DE69002558D1 (de) Zusammensetzungen und methoden zur verhinderung von inkrustierungen.
DE3876075D1 (de) Uv-haertbare und in schattengebieten mit feuchtigkeit haertbare zusammensetzungen.
ZA844592B (en) Composition for treating allergy
DE69205535D1 (de) Verfahren zur Herstellung von Phenylbutyronitrilen und Verwendung in der Parfümerie des 2,2-Dimethyl-4-Phenyl-Valeriannitrile.
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
DE68913995D1 (de) Zusammensetzung zur behandlung progressiver myopie.
DE69000960D1 (de) Zusammensetzung zur behandlung von pigmentierung.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8339 Ceased/non-payment of the annual fee